NEIL1 suppresses ROS accumulation to promote temozolomide resistance and malignant progression in glioma cells
NEIL1 drives glioma malignancy and TMZ resistance by mitigating oxidative stress and DNA damage, highlighting its role as a promising target to overcome chemoresistance.
Authors
- Qingyue Yuan (ORCID: https://orcid.org/0009-0002-6775-5080)
- Xianzhen Chen (ORCID: https://orcid.org/0000-0003-1915-4686)
- Chenhao Fang
- Shuo Li
Institutions
- Tongji University (CN)
- Shanghai Tenth People's Hospital (CN)
Publication Details
- Journal
- Translational Oncology
- Published
- 2026-01-13
- DOI
- https://doi.org/10.1016/j.tranon.2026.102667
- Primary Topic
- RNA regulation and disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00